Lexaria Bioscience annual operating margin
2016
2021
2022
2023
2024
2025
Lexaria Bioscience Operating Margin Growth & History (LEXX)
Lexaria Bioscience's operating margin was −1,683.01% for fiscal 2025.
View full Lexaria Bioscience company overviewLexaria Bioscience annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-08-31 | −1,683.01% | −443.85 pp |
| 2024 | 2024-08-31 | −1,239.16% | +1649.35 pp |
| 2023 | 2023-08-31 | −2,888.50% | −296.84 pp |
| 2022 | 2022-08-31 | −2,591.67% | −1804.82 pp |
| 2021 | 2021-08-31 | −786.85% | +2349.97 pp |
| 2016 | 2016-08-31 | −3,136.82% | — |
Lexaria Bioscience quarterly operating margin
Q2.16
Q3.16
Q1.17
Q2.17
Q1.18
Q2.18
Q3.21
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-02-28 | −7,259.52% | −5796.56 pp |
| Q4 2025 | 2025-08-31 | −1,545.17% | +1077.52 pp |
| Q3 2025 | 2025-05-31 | −2,155.41% | −80.51 pp |
| Q2 2025 | 2025-02-28 | −1,581.04% | −1120.35 pp |
| Q1 2025 | 2024-11-30 | −1,462.95% | −709.94 pp |
| Q4 2024 | 2024-08-31 | −2,622.70% | +1001.50 pp |
| Q3 2024 | 2024-05-31 | −2,074.90% | +1014.73 pp |
| Q2 2024 | 2024-02-29 | −460.69% | +6149.17 pp |
| Q1 2024 | 2023-11-30 | −753.01% | +981.70 pp |
| Q4 2023 | 2023-08-31 | −3,624.19% | −1198.99 pp |
| Q3 2023 | 2023-05-31 | −3,089.64% | −1831.86 pp |
| Q2 2023 | 2023-02-28 | −6,609.86% | −5808.28 pp |
| Q1 2023 | 2022-11-30 | −1,734.71% | +614.44 pp |
| Q3 2022 | 2022-05-31 | −2,425.20% | +1264.55 pp |
| Q3 2021 | 2021-05-31 | −1,257.77% | +3084.26 pp |
| Q2 2018 | 2018-02-28 | −801.58% | +3449.44 pp |
| Q1 2018 | 2017-11-30 | −2,349.15% | −537.37 pp |
| Q2 2017 | 2017-02-28 | −3,689.75% | — |
| Q1 2017 | 2016-11-30 | −4,342.04% | — |
| Q3 2016 | 2016-05-31 | −4,251.02% | — |
| Q2 2016 | 2016-02-29 | −1,811.78% | — |
Lexaria Bioscience operating margin trends
Over the last five reported fiscal years, Lexaria Bioscience's operating margin increased from −3,136.82% to −1,683.01%, a change of +1453.81 percentage points. The latest reported quarter, Q2 2026, shows −7,259.52%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lexaria Bioscience filings at SEC.gov ↗